The following is a summary of “Impact of sodium-glucose cotransporter 2 inhibitors on catheter ablation for atrial fibrillation in heart failure patients without type-2 diabetes,” published in the ...

The temporary pause follows reports of four cases of neurovascular events in the US external evaluation study.

The long-term safety of ibrutinib was proven in patients with newly diagnosed or relapsed or refractory (R/R) chronic ...

Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced European CE mark approval of the Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter for the treatment of cardiac ...

Johnson & Johnson’s JNJ MedTech unit has temporarily paused sales of Varipulse, its pulsed field ablation (PFA) therapy to ...

Johnson & Johnson halted the limited rollout of its Varipulse pulsed field ablation system on Jan. 5 to “investigate the root causes of four reported neurovascular events in the U.S. external ...

The integration of artificial intelligence (AI) into healthcare has opened new frontiers for improving patient care and ...

Tottenham footballer Rodrigo Bentancur collapsed face down on the pitch just five minutes into a match against Liverpool. The ...

Johnson & Johnson pauses U.S. Varipulse cases to investigate neurovascular events. The FDA-approved device integrates PFA ...

These are our selections for the Best of CES 2025 Awards, focusing on products that stand out for their innovation and ...

Pulse Biosciences, Inc. (the "Company" or "Pulse Biosciences"), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablationtm (nano-PFA or nsPFAtm) technology, today announced the ...

These are tech expert Marc Salzman's top CES picks for USA TODAY after his hands-on with future gadgets and gear in Las Vegas ...